DUBLIN--(BUSINESS WIRE)--Jun 6, 2018--The "Metabolomics Market by Product & Service - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The global metabolomics market accounted for $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023.

Metabolomics is an emerging field of science that performs systematic quantification and classification of metabolites in a biological system by using sophisticated analytical technologies. The analytical techniques used include spectroscopy, chromatography, and multivariate analysis.

The global metabolomics market is driven by continues technological advancements in medical devices and adoption of metabolomics in precision medicine. Moreover, increased private & government funding for metabolomics R&D activities is expected to propel the market growth during the forecast period. However, high cost of analytical equipment & maintenance and lack of effective data management for metabolomics profiling are expected to hamper the market growth.

The global metabolomics market is segmented based on product & service, application, indication, and geography. Based on the product & service, it is categorized into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment is further divided into separation techniques and detection techniques. The separation techniques segment is further classified into high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. The detection techniques segment is further categorized into mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis.

Key Vendors:

Agilent Technologies, Inc. Danaher Corporation Biocrates Life Sciences AG Bruker Corporation Leco Corporation Metabolon, Inc. Human Metabolome Technologies, Inc. Bio-Rad Laboratories, Inc. Shimadzu Corporation Waters Corporation Thermo Fisher Scientific Inc.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Global Metabolomics Market, By Product & Service

Chapter 5 Global Metabolomics Market, By Application

Chapter 6 Global Metabolomics Market, By Indication

Chapter 7 Global Metabolomics Market, By Geography

Chapter 8 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/2r6566/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180606005562/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/06/2018 06:04 AM/DISC: 06/06/2018 06:04 AM

http://www.businesswire.com/news/home/20180606005562/en